Ageing Curtails the Diversity and Functionality of Nascent CD8 + T Cell Responses against SARS-CoV-2.
Davide ProiettoBeatrice DallanEleonora GalleraniValentina AlbaneseSian Llewellyn-LaceyDavid A PriceVictor AppaySalvatore PacificoAntonella CaputoFrancesco NicoliRiccardo GavioliPublished in: Vaccines (2023)
Age-related changes in the immune system are thought to underlie the vulnerability of elderly individuals to emerging viral diseases, such as coronavirus disease 2019 (COVID-19). In this study, we used a fully validated in vitro approach to determine how age impacts the generation of de novo CD8 + T cell responses against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19. Our data revealed a generalized deficit in the ability of elderly individuals to prime the differentiation of naïve precursors into effector CD8 + T cells defined by the expression of interferon (IFN)-γ and the transcription factor T-bet. As a consequence, there was an age-related decline in the diversity of newly generated CD8 + T cell responses targeting a range of typically immunodominant epitopes derived from SARS-CoV-2, accompanied by an overall reduction in the expression frequency of IFN-γ. These findings have potential implications for the development of new strategies to protect the elderly against COVID-19.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- dendritic cells
- poor prognosis
- middle aged
- transcription factor
- community dwelling
- immune response
- binding protein
- long non coding rna
- regulatory t cells
- climate change
- cancer therapy
- electronic health record
- big data
- dna binding
- human health
- artificial intelligence
- genome wide identification